SRX Global issues shareholder update on ARMR Sciences portfolio company
SRX Global Inc. says it is providing a shareholder update on its portfolio company, ARMR Sciences, a clinical-stage biodefense company.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.